Navigation Links
Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results
Date:5/14/2009

se of CPP-109 for the treatment of cocaine addiction by the end of the second quarter of 2009. Assuming positive data, we will likely seek to meet with the FDA and begin designing the Phase III 'pivotal' cocaine trial during the second half of 2009 that we believe will be required in order to meet our ultimate goal of filing an NDA for CPP-109. In addition, we also expect to have the top-line results of our 57-patient proof-of-concept study evaluating the use of CPP-109 in the treatment of methamphetamine addiction during the third quarter of 2009. Furthermore, we believe that our strengthened balance sheet will enable us to engage prospective corporate partners and explore a variety of potential transactions on terms that may prove to be favorable to our stockholders."

"Additionally, we are actively exploring opportunities to obtain government funding from agencies that operate under the National Institutes of Health umbrella to further our development plans, which include developing large-scale clinical trials using CPP-109 to treat cocaine and methamphetamine addiction, as well as pilot studies for other addictions including alcohol and nicotine dependence."

About Catalyst Pharmaceutical Partners

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for nine patents in the United States relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive-compulsive disorders . Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending in more than 30 countries. The Company's initial product candidate based on vigabatrin is CPP-109. CPP-109 has been granted "Fast Track" status
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
4. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
5. CATalyst Summit Declared a Success: Its All About the Cat!
6. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
7. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
8. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
9. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
10. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
11. CATalyst Council Forms to Address Feline Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... November 28, 2014 Lice Troopers Lice Removal ... its in-home head lice service for moms in Miami-Dade ... center of Coral Gables on Pone De-leon Blvd in Miami. ... Islands that service Miami-Dade & Broward. Lice Troopers is ... South Florida which has been treating families for several years. ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 "Most of my ... me to use crutches," said an inventor from Findlay, Ohio. ... convenient way to support my foot, which inspired me to ... to offer a convenient way to support an injured foot. ... around. It eliminates the need for crutches. The design redistributes ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic and ... to its students. That is why the Virginia ... structure at its mental health services facility in ... for children who are identified as needing additional ... served the needs of children with severe emotional ...
(Date:11/28/2014)... Brentwood, TN (PRWEB) November 28, 2014 ... in Tennessee for the first time. PAI Medical Group ... M.D. will be performing a robotic hair transplant procedure ... at 9:00 A.M. , The first in Tennessee and ... PAI Medical Group now offers ARTAS robotic hair transplantation. ...
(Date:11/28/2014)... Most of the people attending a presentation by Ken Farmer ... Woods retirement community found out the “prized” possessions they ... have made the cut to be on an “Antiques Roadshow” ... and folk art and his appearances on the PBS program ... and selling antiques. Broadly speaking the antiques market is ...
Breaking Medicine News(10 mins):Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2Health News:Antiques Appraiser Sheds Light on "Treasures" 2
... Food and Drug Administration (FDA) and Roxane Labs have ... are used in patients with severe// rheumatoid arthritis as ... ,"It was discovered that a single bottle of ... 2.5 mg. While we believe this issue may be ...
... local newspaper to pay compensation and apologise to a young ... unethical reporting.// ,Beijing Chaoyang District Court ordered the ... (2,500 US dollars) and issue an apology on its front ... carried three photos of the woman and the story of ...
... companies have evinced interest to invest in India ... committing Rs 1,665 crore investment for capacity expansion ... and Fertilisers Minister Ram Vilas Paswan said here. ... to Japan recently, said during his trip significant ...
... is not healthy to lose weight soon after giving birth, ... the pitfalls of following celebrity trends//, and aspiring for an ... serious effects on the health of the mother and the ... the baby’s birth, is a time for building nutrition ...
... Health (MOH) says that Singapore will soon conduct a ... Readiness.// , More than 1,000 personnel from ... of Education, the Civil Aviation Authority of Singapore, Immigration ... in the exercise code-named SPARROWHAWK II. , ...
... lakh equity shares to Ranbaxy Laboratories on a preferential basis ... directors has approved the issue of 20 lakh equity shares ... a preferential basis to Ranbaxy, subject to shareholders' approval, the ... approved the allotment of shares over 1.11 crore equity shares ...
Cached Medicine News:
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... Nov. 26, 2014  Aridis Pharmaceuticals, Inc., a ... therapies for infectious diseases, announced today the addition ... recognized key opinion leader in the areas of ... board. Founder and Chief Executive Officer, ... Dr. Opal,s extensive experience investigating bacterial toxins and ...
(Date:11/26/2014)... and NEW YORK ... As the leading distributor of market intelligence, ... new research report by IQ4I Research and Consultancy focusing ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast to ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Beginning today, Northside Hospital and Atlanta Perinatal Consultants announce ... test for common fetal trisomies, such as trisomy 21 ... Edwards syndrome. The Harmony Prenatal Test, ... testing platform to analyze DNA in maternal blood so ...
... 26, 2012 Quest International, Inc., a leading global ... solutions, announced today that is has contributed $5000 to ... the American Cancer Society Key Gala, that benefits the ... Massachusetts on Thursday, March 29, 2012. "We ...
Cached Medicine Technology:Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 2Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 3Quest International Donates $5000 to the American Cancer Society 2
Stainless steel lockable wall display for up to 12 frames....
... display system provides maximum impact for the ... unique approach to displaying frames allows your ... create appealing, flexible and eye-catching displays. The ... your patients are motivated. Removable holders. Variable ...
Single Eyevee 2.0 Frame Clip. Available in black, clear and silver colors....
... ClinicDB is a multi-page ... that maintains a database of ... microscopy results, adverse reactions, etc. ... reports, letters and invoices that ...
Medicine Products: